Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2013; 45(10): 1319-1324
DOI: 10.1055/s-0032-1318507
DOI: 10.1055/s-0032-1318507
paper
Novel Synthesis of Butyl (S)-2-Hydroxybutanoate, the Key Intermediate of PPARα Agonist (R)-K-13675 from Butyl (2S,3R)-Epoxybutanoate and Butyl (S)-2,3-Epoxypropanoate
Further Information
Publication History
Received: 08 February 2013
Accepted after revision: 06 March 2013
Publication Date:
03 April 2013 (online)
![](https://www.thieme-connect.de/media/synthesis/201310/lookinside/thumbnails/10.1055-s-0032-1318507-1.jpg)
Abstract
Novel synthetic methods for the production of butyl (S)-2-hydroxybutanoate starting from butyl (2S,3R)-epoxybutanoate or butyl (S)-2,3-epoxypropanoate were established. The former method utilized the regioselective thiolysis of the epoxybutanoate mediated by scandium triflate and subsequent reductive cleavage of the thioether to give butyl (S)-2-hydroxybutanoate with stereochemical retention in quantitative yield. The latter method utilized one-step conversion by a combination of methylmagnesium bromide and copper catalyst in high yield.
-
References
- 1a Yamazaki Y, Abe K, Toma T, Nishikawa M, Ozawa H, Okuda A, Araki T, Oda S, Inoue K, Shibuya K, Staels B, Fruchart JC. Bioorg. Med. Chem. Lett. 2007; 17: 4689
- 1b Kitajima K, Miura S, Matsuo Y, Uehara Y, Saku K. Atherosclerosis 2009; 203: 75
- 2a Jares-Erijiman EA, Ingrum AL, Carney JR, Rinehart KL, Sakai R. J. Org. Chem. 1993; 58: 4805
- 2b Brewster F, Hiron F, Hughes ED, Ingold CK, Rao PA. D. S. Nature (London) 1950; 166: 179
- 2c Koga K, Taniguchi M, Yamada S. Tetrahedron Lett. 1971; 12: 263
- 2d Gringore OH, Rouessac FP. Org. Synth. 1985; 63: 121
- 2e Sugita M. JP 2011093869, 2011
- 3a Yamazaki Y, Araki T, Koura M, Shibuya K. Synthesis 2008; 1017
- 3b Yamazaki Y, Araki T, Koura M, Shibuya K. Tetrahedron 2008; 64: 8155
- 4 Davis FA, Chen BC. Chem. Rev. 1992; 92: 919
- 6a Nakamura K, Inoue K, Ushio K, Oka S, Ohno A. J. Org. Chem. 1988; 53: 2589
- 6b Nakamura K, Yamanaka R, Matsuda T, Harada T. Tetrahedron: Asymmetry 2003; 14: 2659
- 7 Burk MJ, Kalberg CS, Pizzano A. J. Am. Chem. Soc. 1998; 120: 4345
- 8 Both compounds are commercially available from Osaka Organic Chemical Industry Ltd.; they can be easily prepared from the corresponding racemic epoxypropanoate and trans-2,3-epoxybutanoate by the treatment with protease: Akaishi R, Tsutsumi A, Araki S, Hirose Y, Ohno A. JP 2000166592, 2000
- 9a Behrens CH, Sharpless KB. J. Org. Chem. 1985; 50: 5696
- 9b Chong JM, Sharpless KB. Tetrahedron Lett. 1985; 26: 4683
- 9c Amantini D, Fringuelli F, Pizzo F, Vaccaro L. J. Org. Chem. 2001; 66: 4463
- 9d Gleason JG, Hall RF, Perchonock CD, Erhard KF, Frazee JS, Ku TW, Kondrad K, McCarthy ME, Mong S. J. Med. Chem. 1987; 30: 959
- 10a Koura M, Yamazaki Y, Shibuya K. WO 2007013555, 2007
- 10b Compagnone RS, Rapoport H. J. Org. Chem. 1986; 51: 1713
- 10c Romanelli MN, Bartolini A, Bertucci C, Dei S, Ghelardini C, Giovannini MG, Gualtieri F, Pepeu G, Scapecchi S, Teodori E. Chirality 1996; 8: 225
- 11a Riego J, Costa A, Saa JM. Chem. Lett. 1986; 1565
- 11b Chong JM, Sharpless KB. J. Org. Chem. 1985; 50: 1560
- 11c Aggarwal VK, Charmant JP. H, Fuentes D, Harvey JN, Hynd G, Ohara D, Picoul W, Robiette R, Smith C, Vasse JL, Winn CL. J. Am. Chem. Soc. 2006; 128: 2105
- 11d Flisak JR, Gombatz KJ, Holmes MM, Jarmas AA, Lantos I, Mendelson WL, Novack VJ, Remich JJ, Snyder L. J. Org. Chem. 1993; 58: 6247
- 11e Puschmann I, Erker T. Heterocycles 1995; 41: 709
- 11f Hashiyama T, Inoue H, Takeda M, Murata S, Nagao T. Chem. Pharm. Bull. 1985; 33: 2348
- 11g Hashiyama T, Inoue H, Konda M, Takeda M. J. Chem. Soc., Perkin Trans. 1 1984; 1725
- 11h Ranu BC, Mandal T. Can. J. Chem. 2006; 84: 762
- 12 We postulated that THF can be cleaved under these conditions. Whereas ZnCl2 is too weak a Lewis acid to open the THF ring
- 13 March J. Advanced Organic Chemistry . 4th ed. Wiley-VCH; Weinheim: 1992: 350
- 14 Sc(OTf)3 in bulk for multi-kg scale is commercially available from Shanghai Synchem Technology and Sinofluoro Scientific Co., Ltd. (China).
- 15 Node M, Kumar K, Nishide K, Ohsugi S, Miyamoto T. Tetrahedron Lett. 2001; 42: 9207
- 16 Benzene in pharmaceutical products must be controlled to less than 2 ppm as organic volatile impurities under the ICH Q3C guidelines.
- 17 The optical purity of 2 was determined by converting it into its 4-nitrobenzoate and then examining it by HPLC analysis, see also ref. 3b.
- 18a Kobayashi S. Chem. Lett. 1991; 2187
- 18b Barrett AG. M, Braddock DC. Chem. Commun. 1997; 351
- 19a Ashby EC, Smith RS, Goel AB. J. Org. Chem. 1981; 46: 5133
- 19b Larcheveque M, Perit Y. Tetrahedron Lett. 1987; 28: 1993
- 20a Perrone MG, Santandrea E, Nunno LD, Scilimati A, Tortorella V, Capitelli F, Bertolasi V. Tetrahedron: Asymmetry 2005; 16: 783
- 20b Diaz M, Ibarzo J, Ortuno RM. Tetrahedron: Asymmetry 1994; 5: 37
- 20c Diaz M, Ortuno RM. Tetrahedron: Asymmetry 1995; 6: 1845
- 21 Parida S, Dordick JS. J. Am. Chem. Soc. 1991; 113: 2253
This mechanism presumably involves anchimeric assistance of the carboxy group in the decomposition of an intermediate diazonium ion, leading to an α-hydroxy acid with retention of configuration. See the following reference:
The reaction of butyl (S)-2-bromobutanoate obtained via diazotization of (S)-2-aminobutanoic acid with phenol accompanied with racemization (~81% ee):
Refer to the following articles:
Refer to the following articles: